Back to Search
Start Over
A revised biosynthetic pathway for the cofactor F420 in bacteria
- Publication Year :
- 2018
- Publisher :
- Cold Spring Harbor Laboratory, 2018.
-
Abstract
- Cofactor F420plays critical roles in primary and secondary metabolism in a range of bacteria and archaea as a low-potential hydride transfer agent. It mediates a variety of important redox transformations involved in bacterial persistence, antibiotic biosynthesis, pro-drug activation and methanogenesis. However, the biosynthetic pathway for F420has not been fully eluci-dated: neither the enzyme that generates the putative intermediate 2-phospho-L-lactate, nor the function of the FMN-binding C-terminal domain of the γ-glutamyl ligase (FbiB) in bacteria are known. Here we show that the guanylyltransferases FbiD and CofC accept phosphoenolpyruvate, rather than 2-phospho-L-lactate, as their substrate, leading to the formation of the previously uncharacterized intermediate, dehydro-F420-0. The C-terminal domain of FbiB then utilizes FMNH2 to reduce dehydro-F420-0, which produces mature F420species when combined with the γ-glutamyl ligase activity of the N-terminal domain. This new insight has allowed the heterologous expression F420from a recombinant F420biosynthetic pathway inEscherichia coli.
- Subjects :
- chemistry.chemical_classification
0303 health sciences
DNA ligase
biology
030306 microbiology
Chemistry
medicine.disease_cause
biology.organism_classification
Cofactor
03 medical and health sciences
Biochemistry
13. Climate action
biology.protein
medicine
Ligase activity
Heterologous expression
Secondary metabolism
Phosphoenolpyruvate carboxykinase
Escherichia coli
Bacteria
030304 developmental biology
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....a41e98147aedf75cb5ae6eea99707291
- Full Text :
- https://doi.org/10.1101/470336